MCO Form 4: Fauber exercises options, sells 415 shares under 10b5-1 plan
Rhea-AI Filing Summary
Robert Fauber, President and CEO of Moody's Corporation (MCO), reported option exercises and a sale executed pursuant to a Rule 10b5-1 plan adopted July 30, 2024. On 09/15/2025 he had three option-related acquisitions: 56, 134 and 91 shares tied to employee stock options with exercise prices $80.81, $94.18 and $113.34, respectively. The filing shows a contemporaneous sale of 415 common shares at $512.65. Following the reported transactions, Fauber's beneficial common stock holdings are shown around 61,349.984–61,764.984 shares depending on each line item. The report was signed by Elizabeth McCarroll by power of attorney on 09/16/2025.
Positive
- Transactions executed under a Rule 10b5-1 plan, indicating pre-planned, compliant insider trading
- Option vesting follows stated schedules, consistent with standard executive compensation practices
Negative
- None.
Insights
TL;DR: Transaction executed under an existing 10b5-1 plan; routine executive option exercises with a small open-market sale.
The report documents standard executive compensation activity: vesting-scheduled option exercises and a sale of 415 shares under a pre-established Rule 10b5-1 trading plan adopted July 30, 2024. Vesting schedules referenced indicate options vest one-fourth annually from stated grant dates, consistent with typical multi-year grants. The filing is procedural and compliant with Section 16 reporting requirements; it does not disclose any corporate developments or material operational metrics.
TL;DR: Option exercises increase insider-held shares modestly while a small sale occurred; no new information on company performance.
The filing shows three option exercises (56, 134, 91 shares) at exercise prices of $80.81, $94.18 and $113.34 respectively, and an associated open-market sale of 415 shares at $512.65. The transactions were processed via a Rule 10b5-1 plan, reducing signaling risk. Post-transaction beneficial ownership totals are reported in the low 61,000-share range across lines. There is no revenue, earnings, or strategic disclosure to change valuation assumptions.